Sofosbuvir 400 mg

Hopforhep is a breakthrough new medication for the treatment of patients with chronic hepatitis C. Sofosbuvir is a direct-acting antiviral agent and interferes with the HCV lifecycle, restraining the viral replication, allows most patients to be treated successfully without the use of peginterferon an injectable drug with severe side effects.

For more information about this product click on the links below:

+ Professionals

+ Consumer

+ Diseases & conditions

Copyright © 2017 Global Napi Pharmaceuticals.All rights reserved.
Designed & Developed by | VisionApps Team.